Aida Rechdouni, M.D.
NPI 1699814533 · Anatomic Pathology Physician · La Crescenta, CA
Enrolled with Medicare as Practitioner - Pathology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Aida Rechdouni, M.D. is a Anatomic Pathology Physician provider in La Crescenta, CA (NPI 1699814533).
Provider details
- NPI number
- 1699814533
- Entity type
- Individual
- Primary specialty
- Anatomic Pathology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- Yes
- License
- A72786 (CA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Laboratories
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
7,722 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305 | 4,204 | $66 |
| Special Stained Specimen Slides to Examine Tissue Including Interpretation and Report88313 | 2,021 | $76 |
| Special Stained Specimen Slides to Identify Organisms Including Interpretation and Report88312 | 1,366 | $103 |
| Special Stained Specimen Slides to Examine Tissue, Initial Procedure88342 | 91 | $109 |
| Cell Examination of Specimen, Selective Cellular Enhancement Technique88112 | 40 | $77 |
Typical Medicare-allowed amounts for these services range $66–$109 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, not a price quote and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) |
|---|---|
| Cyclosporine | 18 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 18 |
| Azelastine Hcl | 12 |
| Empagliflozin/Metformin Hclbrand: Synjardy | 12 |
| Levothyroxine Sodium | 11 |
| Memantine Hclbrand: Memantine Hcl Er | 11 |
| Pantoprazole Sodium | 11 |
| Trazodone Hcl | 11 |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$18 across 1 record (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2007-02-06
- Last updated
- 2026-02-24
- Certified
- 2026-02-24
Frequently asked questions
- What is Aida Rechdouni's NPI number?
- Aida Rechdouni's National Provider Identifier (NPI) is 1699814533, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Aida Rechdouni's specialty?
- Aida Rechdouni is listed in the NPPES registry with a primary specialty of Anatomic Pathology Physician (Allopathic & Osteopathic Physicians).
- Where is Aida Rechdouni located?
- Aida Rechdouni's practice location on file with NPPES is 2626 Foothill Blvd Ste 102, La Crescenta, CA 91214-3574.
- What is Aida Rechdouni's phone number?
- The practice phone number listed in the NPPES registry for Aida Rechdouni is (888) 610-8909.
- Does Aida Rechdouni accept Medicare?
- Aida Rechdouni is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Aida Rechdouni's NPI active?
- Yes — Aida Rechdouni's NPI (1699814533) is active in the NPPES registry as of the last update on 2026-02-24.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.